News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Progen Pharmaceuticals Limited (PGLA) - Avexa Limited (AVX.AX) Merger Update


1/30/2009 9:25:32 AM

BRISBANE, Australia--(BUSINESS WIRE)--The directors of Progen Pharmaceuticals Limited (“Progen”) (ASX:PGL) (NASDAQ:PGLA) confirm their unanimous recommendation for the proposed merger with Avexa Limited (“Avexa”) (ASX:AVX). The board believes that the current merger proposal with Avexa has the potential to deliver value in excess of $1.35 per share and hence is in the best interests of shareholders as a whole.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES